Beauty Health (SKIN) Stock Price, News & Analysis

-0.03 (-1.08%)
(As of 05/17/2024 ET)
Today's Range
50-Day Range
52-Week Range
951,987 shs
Average Volume
1.83 million shs
Market Capitalization
$338.20 million
P/E Ratio
Dividend Yield
Price Target

Beauty Health MarketRank™ Stock Analysis

Analyst Rating
1.92 Rating Score
129.4% Upside
$6.29 Price Target
Short Interest
13.00% of Float Sold Short
Dividend Strength
News Sentiment
0.86mentions of Beauty Health in the last 14 days
Based on 24 Articles This Week
Insider Trading
Proj. Earnings Growth
From ($0.03) to $0.03 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

3.15 out of 5 stars

Medical Sector

341st out of 920 stocks

Surgical & Medical Instruments Industry

49th out of 99 stocks

SKIN stock logo

About Beauty Health Stock (NASDAQ:SKIN)

The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a Delivery System designs to connects providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive, a treatment for scalp health. The company was founded in 1997 and is headquartered in Long Beach, California.

SKIN Stock Price History

SKIN Stock News Headlines

The 2024 Very T&C Beauty Classics
Beauty Health (NASDAQ:SKIN) PT Lowered to $3.00
Update: SKIN, May 10
See More Headlines
Receive SKIN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Beauty Health and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
Next Earnings (Estimated)
Fiscal Year End

Industry, Sector and Symbol

Surgical & medical instruments
Current Symbol
Year Founded

Price Target and Rating

Average Stock Price Target
High Stock Price Target
Low Stock Price Target
Potential Upside/Downside
Consensus Rating
Rating Score (0-4)
Research Coverage
12 Analysts


Net Income
Pretax Margin


Sales & Book Value

Annual Sales
$398 million
Book Value
$0.51 per share


Free Float
Market Cap
$338.20 million
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Key Executives

  • Ms. Marla Malcolm Beck (Age 54)
    President, CEO & Director
    Comp: $31.49k
  • Mr. Daniel Copell Watson (Age 61)
    Chief Revenue Officer
    Comp: $777.36k
  • Mr. Michael P. Monahan (Age 52)
    Chief Financial Officer
  • Ms. Sheri Lewis (Age 58)
    Chief Supply Chain & Operations Officer
  • Eduardo Rodriguez
    Senior Director of M&A and Investor Relations
  • Mr. Paul Bokota
    VP & General Counsel
  • Ms. Celeste Ortiz
    Chief Human Resources Officer
  • Mr. Mingo Ku
    President of APAC
  • Mr. Jon Arnold
    President of EMEA

SKIN Stock Analysis - Frequently Asked Questions

Should I buy or sell Beauty Health stock right now?

12 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Beauty Health in the last twelve months. There are currently 3 sell ratings, 7 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "reduce" SKIN shares.
View SKIN analyst ratings
or view top-rated stocks.

What is Beauty Health's stock price target for 2024?

12 brokerages have issued 12-month price objectives for Beauty Health's stock. Their SKIN share price targets range from $2.50 to $23.00. On average, they predict the company's stock price to reach $6.29 in the next twelve months. This suggests a possible upside of 129.4% from the stock's current price.
View analysts price targets for SKIN
or view top-rated stocks among Wall Street analysts.

How have SKIN shares performed in 2024?

Beauty Health's stock was trading at $3.11 on January 1st, 2024. Since then, SKIN stock has decreased by 11.9% and is now trading at $2.74.
View the best growth stocks for 2024 here

When is Beauty Health's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, August 14th 2024.
View our SKIN earnings forecast

How were Beauty Health's earnings last quarter?

The Beauty Health Company (NASDAQ:SKIN) issued its quarterly earnings results on Thursday, May, 9th. The company reported ($0.10) earnings per share for the quarter, topping the consensus estimate of ($0.14) by $0.04. The company earned $81.40 million during the quarter, compared to analyst estimates of $80.56 million. Beauty Health had a negative net margin of 20.48% and a negative trailing twelve-month return on equity of 0.02%. The business's quarterly revenue was down 5.7% on a year-over-year basis. During the same period in the prior year, the business earned ($0.17) EPS.

What guidance has Beauty Health issued on next quarter's earnings?

Beauty Health issued an update on its second quarter 2024 earnings guidance on Thursday, May, 9th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $96.0 million-$102.0 million, compared to the consensus revenue estimate of $107.2 million.

Who are Beauty Health's major shareholders?

Beauty Health's stock is owned by a variety of retail and institutional investors. Top institutional investors include Janus Henderson Group PLC (9.14%), Vanguard Group Inc. (4.50%), Jacobs Levy Equity Management Inc. (0.78%), Susquehanna Portfolio Strategies LLC (0.29%), Bayesian Capital Management LP (0.09%) and 180 Wealth Advisors LLC (0.07%). Insiders that own company stock include Brent L Saunders, Doug K Schillinger and Michael P Monahan.
View institutional ownership trends

How do I buy shares of Beauty Health?

Shares of SKIN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:SKIN) was last updated on 5/19/2024 by Staff

From Our Partners